Microchips in Medicine Market Size & Share, by Application (Drug Administration, Home Monitoring); End-user (Hospital, Research Centers) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 3734
  • Published Date: Apr 04, 2023
  • Report Format: PDF, PPT

Companies Dominating the Microchips in Medicine Landscape

top-features-companies
    • Thermo Fisher Scientific Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Applied Microarrays Inc.
    • RELX Group
    • QIAGEN
    • Agilent Technologies, Inc.
    • INTROMEDIC
    • Otsuka America Pharmaceutical, Inc.
    • Medtronic Plc
    • Illumina, Inc.
    • Bio-Rad Laboratories, Inc.

Browse Key Market Insights with Data Illustration:

In-the-news

In The News

  • Thermo Fisher Scientific, Inc., announced it has acquired Belgium-based PharmaFluidics, a manufacturer of micro-chip-based chromatography columns. The acquisition will enable Thermo Fisher to expand its portfolio of chromatography and mass spectrometry solutions. It will also provide customers with access to advanced technology for analyzing complex samples.
  •  Medtronic plc has announced Cosmo Pharmaceuticals and NVIDIA are planning to integrate their AI technology into its intelligent endoscopy module, GI Genius. By using AI-assisted technology, physicians will be able to detect potentially cancerous polyps more quickly and accurately, leading to better patient outcomes.

Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 3734
  • Published Date: Apr 04, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing popularity of microchip implants in healthcare to improve patient outcomes and the increasing trend of digitalization in healthcare are the major factors driving the growth of the market.

The market size of Microchips in Medicine is anticipated to attain a CAGR of 6% over the forecast period, i.e., 2023-2035.

The major players in the market are Applied Microarrays Inc., RELX Group, QIAGEN, Agilent Technologies, Inc., INTROMEDIC, Otsuka America Pharmaceutical, Inc., Medtronic Plc, Illumina, Inc., Bio-Rad Laboratories, Inc.

The drug administration segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.

The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying